drugset / Trial / NCT02176187

Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease

NCT02176187

Phase 3 Terminated 3 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Study to compare the effect of 'natural' as opposed to 'optimal' technique on the percentage of the dose received from the Respimat® inhaler and metered dose inhaler

Timeline

Start
2003-04
Primary completion
2004-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenoterol Unknown 50 ug Inhaled
Subject Ipratropium Small molecule 20 ug Inhaled